News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Participant advisory group at RECOVER hub raises awareness about Long COVID
The ILLInet PARATROOPers, a a group of RECOVER study participants, collaborate with researchers to center the voices of Long COVID patients, improve RECOVER studies, and raise awareness about the condition.
Feature
46 Results
46 Results
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature
RECOVER-ENERGIZE enrolls first clinical trial participant
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Feature
Long COVID clinic provides access to research studies and care for University of New Mexico patients
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Feature
NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise
RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.
News Release
NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
News Release
Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
Q&A
NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
News Release
RECOVER-NEURO enrolls first participant in trial
RECOVER-NEURO will enroll 315 people and test several different treatments for Long COVID patients who have difficulty focusing, thinking clearly, and remembering things.
News Release